Search Results for: review

By Kuldip K. Ambastha The stock of BeiGene, Ltd. (BGNE), a commercial stage biopharmaceutical company focused on cancer treatment drugs, saw a +20.5% increase in price per share on Wednesday, October 12, 2022. Brukinsa (zanubrutinib) in its Phase 3 trial data showed highly positive results in people with chronic lymphocytic leukemia (CLL) or small lymphocytic …

Continue reading “What Caught Our Attention in the Investment World? – Week of October 10-14, 2022”

By Kuldip K. Ambastha Novavax, Inc. (NVAX), a clinical-stage vaccine company, had its stock price fall by -17.2% per share on Thursday, June 9, 2022. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of December 27-31, 2021; By Kuldip K. Ambastha.”) In 1Q2022, earnings per share plus total …

Continue reading “What Caught Our Attention in the Investment World? – Week of June 6-10, 2022”

By Kuldip K. Ambastha Snap Inc. (SNAP), a social media technology company with smartphone camera application Snapchat as its flagship offering, had its stock price drop by -43.1% per share on Tuesday, May 24, 2022. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of April 20-24, 2020; By …

Continue reading “What Caught Our Attention in the Investment World? – Week of May 23-27, 2022”

By Kuldip K. Ambastha In the past trading week, The Goodyear Tire & Rubber Company (GT) announced plans to acquire Cooper Tire & Rubber Company (CTB). The plans were made public on Monday, February 22, 2021, and on that same trading day Goodyear stock had a +21.0% gain while Cooper stock had a +29.4% gain. …

Continue reading “What Caught Our Attention in the Investment World? – Week of February 22-26, 2021”